The clinical trials listed below are for informational purposes only and are not endorsed by the AST. More information on clinical trials can be found in our clinical trials brochure .Â
Clinical Trials - Recruiting Title Sponsor Organ Type Ages Accepted Expected Completion Date BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation Eledon Pharmaceuticals Kidney 18+ March 31, 2025 An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients with Advanced Cutaneous Malignancies [ARTACUS] Replimune Inc. All organs 18+ April 30, 2026 Tabelecleucel for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE) Atara Biotherapeutics All organs All ages June 30, 2027 An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases (EBVision) Atara Biotherapeutics All organs All ages June 30, 2027
Clinical Trials - Active, Not Recruiting